IL-7 modulates B cells survival and activation by inducing BAFF and CD70 expression in T cells

Journal of Autoimmunity

Volumn 38, Issue 4, 2012, Pages 304-314

  Sammicheli, Stefano ^a   Ruffin, Nicolas ^a   Lantto, Rebecka ^a   Vivar, Nancy ^a   Chiodi, Francesca ^a   Rethi, Bence ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

B cell activation; B cell apoptosis; BAFF; CD70; Interleukin 7

Indexed keywords

B CELL ACTIVATING FACTOR; CD20 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD70 ANTIGEN; INTERLEUKIN 7;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MEMORY CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD70; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SURVIVAL; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; PLASMA CELLS; T-LYMPHOCYTES; UP-REGULATION;

EID: 84861182097     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.01.012     Document Type: Article

References (68)

1. Fry T.J., Mackall C.L. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 2005, 174:6571-6576.
2. Mazzucchelli R., Durum S.K. Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 2007, 7:144-154.
3. Rethi B., Vivar N., Sammicheli S., Chiodi F. Limited efficiency of endogenous interleukin-7 levels in T cell reconstitution during HIV-1 infection: will exogenous interleukin-7 therapy work?. AIDS 2009, 23:745-755.
4. Rethi B., Vivar N., Sammicheli S., Fluur C., Ruffin N., Atlas A., et al. Priming of T cells to Fas-mediated proliferative signals by interleukin-7. Blood 2008, 112:1195-1204.
5. Melchionda F., Fry T.J., Milliron M.J., McKirdy M.A., Tagaya Y., Mackall C.L. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. J Clin Invest 2005, 115:1177-1187.
6. Colombetti S., Levy F., Chapatte L. IL-7 adjuvant treatment enhances long-term tumor-antigen-specific CD8+ T-cell responses after immunization with recombinant lentivector. Blood 2009, 113:6629-6637.
7. Pellegrini M., Calzascia T., Elford A.R., Shahinian A., Lin A.E., Dissanayake D., et al. Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies. Nat Med 2009, 15:528-536.
8. Hartgring S.A., Bijlsma J.W., Lafeber F.P., van Roon J.A. Interleukin-7 induced immunopathology in arthritis. Ann Rheum Dis 2006, 65(Suppl. 3):iii69-iii74.
9. Rihl M., Kellner H., Kellner W., Barthel C., Yu D.T., Tak P.P., et al. Identification of interleukin-7 as a candidate disease mediator in spondylarthritis. Arthritis Rheum 2008, 58:3430-3435.
10. Bikker A, van Woerkom JM, Kruize AA, Wenting-van Wijk M, de Jager W, Bijlsma JW, et al. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjogren's syndrome correlates with increased inflammation. Arthritis Rheum;62:969-977.
11. Bonifati C., Trento E., Cordiali-Fei P., Carducci M., Mussi A., D'Auria L., et al. Increased interleukin-7 concentrations in lesional skin and in the sera of patients with plaque-type psoriasis. Clin Immunol Immunopathol 1997, 83:41-44.
12. Calzascia T., Pellegrini M., Lin A., Garza K.M., Elford A.R., Shahinian A., et al. CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity. Proc Natl Acad Sci U S A 2008, 105:2999-3004.
13. Uehira M., Matsuda H., Hikita I., Sakata T., Fujiwara H., Nishimoto H. The development of dermatitis infiltrated by gamma delta T cells in IL-7 transgenic mice. Int Immunol 1993, 5:1619-1627.
14. Malaspina A., Moir S., Ho J., Wang W., Howell M.L., O'Shea M.A., et al. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc Natl Acad Sci U S A 2006, 103:2262-2267.
15. Malaspina A., Moir S., Chaitt D.G., Rehm C.A., Kottilil S., Falloon J., et al. Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood 2007, 109:2086-2088.
16. Sportes C., Babb R.R., Krumlauf M.C., Hakim F.T., Steinberg S.M., Chow C.K., et al. Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy. Clin Cancer Res 2010, 16:727-735.
17. Pellegrini M, Calzascia T, Toe JG, Preston SP, Lin AE, Elford AR, et al. IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell;144:601-613.
18. Geginat J., Sallusto F., Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med 2001, 194:1711-1719.
19. Elgueta R., Benson M.J., de Vries V.C., Wasiuk A., Guo Y., Noelle R.J. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev 2009, 229:152-172.
20. Agematsu K., Nagumo H., Oguchi Y., Nakazawa T., Fukushima K., Yasui K., et al. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood 1998, 91:173-180.
21. Nagumo H., Agematsu K. Synergistic augmentative effect of interleukin-10 and CD27/CD70 interactions on B-cell immunoglobulin synthesis. Immunology 1998, 94:388-394.
22. Nagumo H., Agematsu K., Shinozaki K., Hokibara S., Ito S., Takamoto M., et al. CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. J Immunol 1998, 161:6496-6502.
23. Arens R., Tesselaar K., Baars P.A., van Schijndel G.M., Hendriks J., Pals S.T., et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 2001, 15:801-812.
24. Tesselaar K., Arens R., van Schijndel G.M., Baars P.A., van der Valk M.A., Borst J., et al. Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Nat Immunol 2003, 4:49-54.
25. Lee W.W., Yang Z.Z., Li G., Weyand C.M., Goronzy J.J. Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis. J Immunol 2007, 179:2609-2615.
26. Oelke K., Lu Q., Richardson D., Wu A., Deng C., Hanash S., et al. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum 2004, 50:1850-1860.
27. Manocha M., Rietdijk S., Laouar A., Liao G., Bhan A., Borst J., et al. Blocking CD27-CD70 costimulatory pathway suppresses experimental colitis. J Immunol 2009, 183:270-276.
28. Nakajima A., Oshima H., Nohara C., Morimoto S., Yoshino S., Kobata T., et al. Involvement of CD70-CD27 interactions in the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 2000, 109:188-196.
29. Oflazoglu E., Boursalian T.E., Zeng W., Edwards A.C., Duniho S., McEarchern J.A., et al. Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis. J Immunol 2009, 183:3770-3777.
30. Mackay F., Schneider P. Cracking the BAFF code. Nat Rev Immunol 2009, 9:491-502.
31. He B, Santamaria R, Xu W, Cols M, Chen K, Puga I, et al. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol;11:836-845.
32. Benson M.J., Dillon S.R., Castigli E., Geha R.S., Xu S., Lam K.P., et al. Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J Immunol 2008, 180:3655-3659.
33. Liu Z., Davidson A. BAFF and selection of autoreactive B cells. Trends Immunol 2011, 32:388-394.
34. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999, 190:1697-1710.
35. Kawabata D., Venkatesh J., Ramanujam M., Davidson A., Grimaldi C.M., Diamond B. Enhanced selection of high affinity DNA-reactive B cells following cyclophosphamide treatment in mice. PLoS One 2010, 5:e8418.
36. Thien M., Phan T.G., Gardam S., Amesbury M., Basten A., Mackay F., et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004, 20:785-798.
37. Groom J.R., Fletcher C.A., Walters S.N., Grey S.T., Watt S.V., Sweet M.J., et al. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med 2007, 204:1959-1971.
38. De Milito A., Nilsson A., Titanji K., Thorstensson R., Reizenstein E., Narita M., et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004, 103:2180-2186.
39. Napolitano L.A., Grant R.M., Deeks S.G., Schmidt D., De Rosa S.C., Herzenberg L.A., et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001, 7:73-79.
40. Fry T.J., Connick E., Falloon J., Lederman M.M., Liewehr D.J., Spritzler J., et al. A potential role for interleukin-7 in T-cell homeostasis. Blood 2001, 97:2983-2990.
41. Kindler V., Zubler R.H. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3. J Immunol 1997, 159:2085-2090.
42. Tangye S.G., Avery D.T., Hodgkin P.D. A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells. J Immunol 2003, 170:261-269.
43. Arpin C., Dechanet J., Van Kooten C., Merville P., Grouard G., Briere F., et al. Generation of memory B cells and plasma cells in vitro. Science 1995, 268:720-722.
44. Jourdan M., Caraux A., De Vos J., Fiol G., Larroque M., Cognot C., et al. An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization. Blood 2009, 114:5173-5181.
45. Goodnow CC, Vinuesa CG, Randall KL, Mackay F, Brink R. Control systems and decision making for antibody production. Nat Immunol;11:681-688.
46. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005, 23:23-68.
47. Hintzen R.Q., Lens S.M., Beckmann M.P., Goodwin R.G., Lynch D., van Lier R.A. Characterization of the human CD27 ligand, a novel member of the TNF gene family. J Immunol 1994, 152:1762-1773.
48. Huang J., Kerstann K.W., Ahmadzadeh M., Li Y.F., El-Gamil M., Rosenberg S.A., et al. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy. J Immunol 2006, 176:7726-7735.
49. Sprent J, Surh CD. Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat Immunol;131:478-484.
50. Krupica T., Fry T.J., Mackall C.L. Autoimmunity during lymphopenia: a two-hit model. Clin Immunol 2006, 120:121-128.
51. Defrance T., Casamayor-Palleja M., Krammer P.H. The life and death of a B cell. Adv Cancer Res 2002, 86:195-225.
52. Scholz J.L., Crowley J.E., Tomayko M.M., Steinel N., O'Neill P.J., Quinn W.J., et al. BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc Natl Acad Sci U S A 2008, 105:15517-15522.
53. Jacobi A.M., Huang W., Wang T., Freimuth W., Sanz I., Furie R., et al. Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum 2010, 62:201-210.
54. Dechanet J., Merville P., Durand I., Banchereau J., Miossec P. The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. J Clin Invest 1995, 95:456-463.
55. Landolt-Marticorena C, Wither R, Reich H, Herzenberg A, Scholey J, Gladman DD, et al. Increased expression of B cell activation factor supports the abnormal expansion of transitional B cells in systemic lupus erythematosus. J Rheumatol;38:642-651.
56. Pers J.O., Daridon C., Devauchelle V., Jousse S., Saraux A., Jamin C., et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci 2005, 1050:34-39.
57. Long D., Blake S., Song X.Y., Lark M., Loeser R.F. Human articular chondrocytes produce IL-7 and respond to IL-7 with increased production of matrix metalloproteinase-13. Arthritis Res Ther 2008, 10:R23.
58. Zhang J., Roschke V., Baker K.P., Wang Z., Alarcon G.S., Fessler B.J., et al. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 2001, 166:6-10.
59. Cheema G.S., Roschke V., Hilbert D.M., Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 2001, 44:1313-1319.
60. Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 2002, 109:59-68.
61. Jacquot S., Kobata T., Iwata S., Morimoto C., Schlossman S.F. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. J Immunol 1997, 159:2652-2657.
62. Breitfeld D., Ohl L., Kremmer E., Ellwart J., Sallusto F., Lipp M., et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 2000, 192:1545-1552.
63. Moir S., Fauci A.S. B cells in HIV infection and disease. Nat Rev Immunol 2009, 9:235-245.
64. De Milito A., Morch C., Sonnerborg A., Chiodi F. Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS 2001, 15:957-964.
65. Nagase H., Agematsu K., Kitano K., Takamoto M., Okubo Y., Komiyama A., et al. Mechanism of hypergammaglobulinemia by HIV infection: circulating memory B-cell reduction with plasmacytosis. Clin Immunol 2001, 100:250-259.
66. Levy Y., Lacabaratz C., Weiss L., Viard J.P., Goujard C., Lelievre J.D., et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest 2009, 119:997-1007.
67. Sereti I., Dunham R.M., Spritzler J., Aga E., Proschan M.A., Medvik K., et al. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 2009, 113:6304-6314.
68. Sportes C., Gress R.E., Mackall C.L. Perspective on potential clinical applications of recombinant human interleukin-7. Ann N Y Acad Sci 2009, 1182:28-38.